Anti-EGFR antibodies and their uses
US8658175B2 · kind B2 · utility
9Cited by
5References
41Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 28, 2010 |
| Grant date | Feb 25, 2014 |
| Priority date | — |
| Expiry date | Oct 28, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention relates to antibodies directed to EGFR and uses of such antibodies, for example, to treat diseases associated with the activity and/or overproduction of EGFR.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.